IBDEI1G4 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23121,1,4,0)
 ;;=4^I16.1
 ;;^UTILITY(U,$J,358.3,23121,2)
 ;;=^8204721
 ;;^UTILITY(U,$J,358.3,23122,0)
 ;;=I16.9^^105^1167^30
 ;;^UTILITY(U,$J,358.3,23122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23122,1,3,0)
 ;;=3^Hypertensive Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,23122,1,4,0)
 ;;=4^I16.9
 ;;^UTILITY(U,$J,358.3,23122,2)
 ;;=^5138600
 ;;^UTILITY(U,$J,358.3,23123,0)
 ;;=I10.^^105^1167^18
 ;;^UTILITY(U,$J,358.3,23123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23123,1,3,0)
 ;;=3^Essentional HTN
 ;;^UTILITY(U,$J,358.3,23123,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,23123,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,23124,0)
 ;;=I48.0^^105^1167^11
 ;;^UTILITY(U,$J,358.3,23124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23124,1,3,0)
 ;;=3^Atrial Fibrillation,Paroxysmal
 ;;^UTILITY(U,$J,358.3,23124,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,23124,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,23125,0)
 ;;=I50.1^^105^1167^22
 ;;^UTILITY(U,$J,358.3,23125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23125,1,3,0)
 ;;=3^Heart Failure,Left
 ;;^UTILITY(U,$J,358.3,23125,1,4,0)
 ;;=4^I50.1
 ;;^UTILITY(U,$J,358.3,23125,2)
 ;;=^5007238
 ;;^UTILITY(U,$J,358.3,23126,0)
 ;;=I48.20^^105^1167^8
 ;;^UTILITY(U,$J,358.3,23126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23126,1,3,0)
 ;;=3^Atrial Fibrillation,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,23126,1,4,0)
 ;;=4^I48.20
 ;;^UTILITY(U,$J,358.3,23126,2)
 ;;=^5158048
 ;;^UTILITY(U,$J,358.3,23127,0)
 ;;=I48.21^^105^1167^12
 ;;^UTILITY(U,$J,358.3,23127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23127,1,3,0)
 ;;=3^Atrial Fibrillation,Permanent
 ;;^UTILITY(U,$J,358.3,23127,1,4,0)
 ;;=4^I48.21
 ;;^UTILITY(U,$J,358.3,23127,2)
 ;;=^304710
 ;;^UTILITY(U,$J,358.3,23128,0)
 ;;=I48.11^^105^1167^9
 ;;^UTILITY(U,$J,358.3,23128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23128,1,3,0)
 ;;=3^Atrial Fibrillation,Longstanding Persistent
 ;;^UTILITY(U,$J,358.3,23128,1,4,0)
 ;;=4^I48.11
 ;;^UTILITY(U,$J,358.3,23128,2)
 ;;=^5158046
 ;;^UTILITY(U,$J,358.3,23129,0)
 ;;=I48.19^^105^1167^10
 ;;^UTILITY(U,$J,358.3,23129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23129,1,3,0)
 ;;=3^Atrial Fibrillation,Oth Persistent
 ;;^UTILITY(U,$J,358.3,23129,1,4,0)
 ;;=4^I48.19
 ;;^UTILITY(U,$J,358.3,23129,2)
 ;;=^5158047
 ;;^UTILITY(U,$J,358.3,23130,0)
 ;;=A15.0^^105^1168^40
 ;;^UTILITY(U,$J,358.3,23130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23130,1,3,0)
 ;;=3^Tuberculosis of Lung
 ;;^UTILITY(U,$J,358.3,23130,1,4,0)
 ;;=4^A15.0
 ;;^UTILITY(U,$J,358.3,23130,2)
 ;;=^5000062
 ;;^UTILITY(U,$J,358.3,23131,0)
 ;;=D86.9^^105^1168^37
 ;;^UTILITY(U,$J,358.3,23131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23131,1,3,0)
 ;;=3^Sarcoidosis,Unspec
 ;;^UTILITY(U,$J,358.3,23131,1,4,0)
 ;;=4^D86.9
 ;;^UTILITY(U,$J,358.3,23131,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,23132,0)
 ;;=E88.01^^105^1168^6
 ;;^UTILITY(U,$J,358.3,23132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23132,1,3,0)
 ;;=3^Alpha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,23132,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,23132,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,23133,0)
 ;;=J18.9^^105^1168^23
 ;;^UTILITY(U,$J,358.3,23133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23133,1,3,0)
 ;;=3^Pneumonia,Unspec Organism
 ;;^UTILITY(U,$J,358.3,23133,1,4,0)
 ;;=4^J18.9
 ;;^UTILITY(U,$J,358.3,23133,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,23134,0)
 ;;=J40.^^105^1168^10
